Rockefeller Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,000
| Closed | -$2K | – | 1990 |
|
|
2022
Q4 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 3529 |
|
|
2022
Q3 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 3546 |
|
|
2022
Q2 | $3K | Hold |
2,000
| – | – | ﹤0.01% | 3608 |
|
|
2022
Q1 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 3384 |
|
|
2021
Q4 | $7K | Hold |
2,000
| – | – | ﹤0.01% | 3124 |
|
|
2021
Q3 | $10K | Hold |
2,000
| – | – | ﹤0.01% | 2875 |
|
|
2021
Q2 | $8K | Hold |
2,000
| – | – | ﹤0.01% | 2851 |
|
|
2021
Q1 | $10K | Hold |
2,000
| – | – | ﹤0.01% | 2570 |
|
|
2020
Q4 | $10K | Sell |
2,000
-339
| -14% | -$1.7K | ﹤0.01% | 2224 |
|
|
2020
Q3 | $18K | Buy |
2,339
+339
| +17% | +$2.61K | ﹤0.01% | 1820 |
|
|
2020
Q2 | $20K | Hold |
2,000
| – | – | ﹤0.01% | 1680 |
|
|
2020
Q1 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 1932 |
|
|
2019
Q4 | $2K | Buy |
+2,000
| New | +$2K | ﹤0.01% | 1900 |
|